As the popularity of medications such as Ozempic® (semaglutide), Trulicity® (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists grow for managing type 2 diabetes and promoting weight loss, the ASA has advised patients to pause these drugs one week before elective surgeries. The gene discussed is GCG; the disease is type 2 diabetes mellitus.